Clinical Trial Update: A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

View source ↗

Summary

This clinical trial aims to evaluate the effects of switching from a biologic treatment to tildrakizumab in adults with moderate-to-severe plaque psoriasis, usi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Status: RECRUITING